Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,581 | -331,942 | 109,625 | -1,281 | -28,144 |
| Depreciation Amortization | 26,268 | 28,684 | 33,700 | 29,271 | 32,111 |
| Income taxes - deferred | N/A | 76,201 | -80,375 | N/A | N/A |
| Accounts receivable | -6,457 | 48,669 | -996 | -11 | 19,800 |
| Other Working Capital | 5,204 | 140 | -13,014 | -31,294 | -52,636 |
| Other Operating Activity | 22,974 | 227,852 | 29,658 | 8,838 | -36,703 |
| Operating Cash Flow | $26,408 | $49,604 | $78,598 | $5,523 | $-65,572 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,911 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -628 | -274 | -53 | 499,216 |
| Net Acquisitions | N/A | 1,531 | -42,399 | -18,472 | 7,585 |
| Sale Of Investment | N/A | 2,194 | N/A | N/A | 6,000 |
| Investing Cash Flow | $-48,911 | $3,097 | $-42,673 | $-18,525 | $512,801 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 70,000 | N/A | N/A |
| Debt Repayment | N/A | -10,500 | -70,750 | -9,835 | -461,256 |
| Common Stock Issued | N/A | N/A | 7,020 | 45,054 | 88 |
| Other Financing Activity | -350 | -33,701 | -14,064 | -6,193 | -7,382 |
| Financing Cash Flow | $-350 | $-44,201 | $-7,794 | $29,026 | $-468,550 |
| Beginning Cash Position | 73,441 | 64,941 | 36,810 | 20,786 | 42,107 |
| End Cash Position | 50,588 | 73,441 | 64,941 | 36,810 | 20,786 |
| Net Cash Flow | $-22,853 | $8,500 | $28,131 | $16,024 | $-21,321 |
| Free Cash Flow | |||||
| Operating Cash Flow | 26,408 | 49,604 | 78,598 | 5,523 | -65,572 |
| Capital Expenditure | N/A | -628 | -274 | -53 | -10 |
| Free Cash Flow | 26,408 | 48,976 | 78,324 | 5,470 | -65,582 |